🎁
DIWALI SPECIAL

20% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

GRANULES vs SANOFICONR: Stock Comparison

GRANULES INDIA vs SANOFI CONS HEALTHC IND LUpdated 30 Oct 26, 10:19 AM ISTNSE & company filings

GRANULES INDIA is the larger company by market capitalisation. SANOFI CONS HEALTHC IND L shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

GRANULES leads 1; SANOFICONR leads 12 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

GRANULESSANOFICONR

Valuation lens

What price are you paying?

Market CapContext only
₹23,331 Cr
₹8,061 Cr
P/E RatioSANOFICONR has the lower reading
31.22x
28.64x ✓
P/B RatioGRANULES has the lower reading
4.1x ✓
23.02x
EPSSANOFICONR has the higher reading
₹26.92
₹29.87 ✓
Book ValueContext only
₹205.21
₹166.73
Dividend YieldSANOFICONR has the higher reading
0.21%
2.16% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
GRANULES is the larger company
₹23,331 Cr vs ₹8,061 Cr
P/E Ratio
SANOFICONR has a lower P/E
28.64x vs 31.22x
P/B Ratio
GRANULES has a lower P/B
4.1x vs 23.02x
EPS
SANOFICONR has higher earnings per share
₹29.87 vs ₹26.92
Dividend Yield
SANOFICONR has a higher dividend yield
2.16% vs 0.21%
Revenue Growth (TTM YoY)
SANOFICONR has faster revenue growth
32.8% vs 22.8%
EPS Growth (TTM YoY)
SANOFICONR has faster EPS growth
35.7% vs 31.3%
Qtr Sales Growth
SANOFICONR has stronger quarterly sales growth
2.84% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGRANULESSANOFICONR
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricGRANULESSANOFICONR
Live Price₹847.9₹3,391
Day Change1.26%-2.22%
Volume2.71 L10,005
52-Week High₹923.65₹5,255
52-Week Low₹529.85₹3,168.2
Distance from 52W High-8.2%-35.47%

Valuation

MetricGRANULESSANOFICONR
Market Cap₹23,331 Cr₹8,061 Cr
P/E Ratio31.22x28.64x
P/B Ratio4.1x23.02x
EPS₹26.92₹29.87
Book Value₹205.21₹166.73
Dividend Yield0.21%2.16%

Growth

MetricGRANULESSANOFICONR
Revenue Growth (TTM YoY)22.8%32.8%
EPS Growth (TTM YoY)31.3%35.7%
Qtr Sales Growth0%2.84%
Qtr Profit Growth0%1.47%

Profitability & Leverage

MetricGRANULESSANOFICONR
ROE9.11%67.16%
ROCE9.07%2,813.76%
Net Margin11.15%27.58%
Operating Margin17.19%37.04%
Debt to Equity0.17x0x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricGRANULESSANOFICONR
Promoter Holding37.08%▼ 0.59 pp71.27%
FII Holding20.25%▲ 2.75 pp2.48%▼ 0.12 pp
DII Holding15.33%▼ 0.78 pp18.03%▲ 0.17 pp
Public Holding27.04%▼ 1.34 pp8.22%▼ 0.05 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GRANULES INDIA and SANOFI CONS HEALTHC IND L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.